<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>CANCER DRUG DEBUNKED</title>
    <meta content="MB000523" name="slug"/>
    <meta content="16" name="publication_day_of_month"/>
    <meta content="7" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Sunday" name="publication_day_of_week"/>
    <meta content="New Jersey Weekly Desk" name="dsk"/>
    <meta content="6" name="print_page_number"/>
    <meta content="14NJ" name="print_section"/>
    <meta content="1" name="print_column"/>
    <meta content="New York and Region" name="online_sections"/>
    <docdata>
      <doc-id id-string="1215303"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <series series.name="BRIEFING: HEALTH"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Cancer</classifier>
        <classifier class="indexing_service" type="descriptor">Advertising</classifier>
        <classifier class="indexing_service" type="descriptor">Misleading and Deceptive Advertising</classifier>
        <classifier class="indexing_service" type="descriptor">Fines (Penalties)</classifier>
        <classifier class="indexing_service" type="descriptor">Fish and Other Marine Life</classifier>
        <classifier class="indexing_service" type="descriptor">Sharks</classifier>
        <classifier class="indexing_service" type="descriptor">Suits and Litigation</classifier>
        <org class="indexing_service">Lane Labs (Co)</org>
        <org class="indexing_service">Federal Trade Commission</org>
        <person class="indexing_service">Suhay, Lisa</person>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/New York and Region</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/New York and Region/New Jersey</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Classifieds/Job Market/Job Categories/Marketing, Advertising and PR</classifier>
        <classifier class="online_producer" type="general_descriptor">Fines (Penalties)</classifier>
        <classifier class="online_producer" type="general_descriptor">Cancer</classifier>
        <classifier class="online_producer" type="general_descriptor">Advertising and Marketing</classifier>
        <classifier class="online_producer" type="general_descriptor">Suits and Litigation</classifier>
        <classifier class="online_producer" type="general_descriptor">Fish and Other Marine Life</classifier>
        <classifier class="online_producer" type="general_descriptor">Diseases and Conditions</classifier>
        <classifier class="online_producer" type="general_descriptor">Animals</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000716T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9807E2DE173BF935A25754C0A9669C8B63" item-length="117" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>CANCER DRUG DEBUNKED</hl1>
      </hedline>
      <byline class="print_byline">By LISA SUHAY</byline>
      <byline class="normalized_byline">Suhay, Lisa</byline>
      <abstract>
        <p>Lane Labs of Alendale, NJ, settles suit by Federal Trade Commission by agreeing to pay $1 million for deceptively marketing products that tout shark cartilage as cancer cure (S)</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>Andrew J. Lane and his father L. William Lane have advocated the use of shark cartilage as a cancer cure. But federal officials say they want sale of the product halted. Lane Labs of Alendale settled a suit by the Federal Trade Commission this month that will cost the company $1 million for deceptively marketing the products called Benefin, SkinAnswer and MGN-3 as cancer cures.</p>
        <p>LISA SUHAY</p>
      </block>
      <block class="full_text">
        <p>Andrew J. Lane and his father L. William Lane have advocated the use of shark cartilage as a cancer cure. But federal officials say they want sale of the product halted. Lane Labs of Alendale settled a suit by the Federal Trade Commission this month that will cost the company $1 million for deceptively marketing the products called Benefin, SkinAnswer and MGN-3 as cancer cures.</p>
        <p>LISA SUHAY</p>
        <p>BRIEFING: HEALTH</p>
      </block>
    </body.content>
  </body>
</nitf>
